Experimental studies of Achyranthes aspera(L) preventing nephrotoxicity induced by lead in albino rats

Journal of Health Science

Volumn 55, Issue 5, 2009, Pages 701-708

  Jayakumar, Thangavel ^a   Sridhar, Metharmitla Perumal ^a   Bharathprasad, Tanguturi Raghavaiah ^a   Ilayaraja, Muthaiyan ^a   Govindasamy, Swaminathan ^a   Balasubramanian, Maruthaiveeran Periyasamy ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Achyranthes aspera; Lead; Nephrotoxicity; Urinary enzyme

Indexed keywords

ACHYRANTHES ASPERA EXTRACT; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BETA GLUCURONIDASE; CATHEPSIN D; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; LEAD ACETATE; N ACETYL BETA GLUCOSAMINIDASE;

ACHYRANTHES; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; KIDNEY MASS; LEAD POISONING; MALE; MEDICINAL PLANT; NEPHROTOXICITY; NONHUMAN; RAT; RAT STRAIN; RENAL PROTECTION; TREATMENT OUTCOME;

ACHYRANTHES ASPERA; RATTUS;

EID: 70350238494     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.55.701     Document Type: Article

References (47)

1. Mahmoud, L. A. (1997) Renal effects of environmental and occupational lead exposure. Environ. Health Perspect., 105, 928-939.
2. Yu, C. C., Lin, J. L. and Lin-Tan, D. T. (2004) Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J. Am. Soc. Nephrol., 15, 1016-1022.
3. Kitman, J. L. (2000) The Secret History of Lead. Nation., 40, 1-23.
4. Goyer, R. A. and Rhyne, B. C. (1973) Pathological effects of lead. Int. Rev. Exp. Pathol., 12, 1-77.
5. Lilis, R. and Landrigan, P. J. (1988) Renal and urinary tract disorders. In Occupational Health: Recognizing and Preventing Work-Related Disease (Levy, B. S. and Wegman, D. H., Eds.), 2nd ed., Boston: Little, Brown and Co., pp. 465-476.
6. Price, R. G. (1992) The role of NAG (N-acetyl-β-dglucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity, Clin. Nephrol., 38, 514-519.
7. Loeb, W. F. (1998) The measurement of renal injury. Toxicol. Pathol., 26, 26-28.
8. Taylor, S. A., Chivers, I. D., Price, R. G., Arce-Tomas, M.,Milligan, P. and Francini, I. (1997) The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ. Res., 75, 23-33.
9. Gibey, R., Dupond, J. L., Alber, D., Leconte des Floris, R. and Henry, J. C. (1981) Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2- microglobulin (beta 2 M) in evaluating nephrotoxicity of gentamicin. Clin. Chim. Acta, 116, 25-34.
10. Scherberich, J. E. and Mondorf, W. A. (1983) Assessment of drug nephrotoxicity by the excretion of tubule specific membrane antigens and enzymes. Z. Gesamte Inn. Med., 38, 571-580.
11. Naidu, S. G. and Lee, F. T. Jr. (1994) Contrast nephrotoxicity: predictive value of urinary enzyme markers in a rat model. Acad. Radiol., 1, 3-9.
12. Ann O'Hara, M., Kiefer, D., Farrell, K. and Kemper, K. (1998) A Review of 12 Commonly Used Medicinal Herbs. Arch. Fam. Med., 7, 523-536. (Pubitemid 128433264)
13. Nadkarni, K. M. and Nadkarni, A. K. (1976) Indian Materia Medica, vol.1, Popular Prakashan, Bombay, p. 21.
14. Kapoor, V. K. and Harkishan, S. (1967) Investigation of Achyranthes aspera Linn. Indian J. Pharmacol., 29, 285-288.
15. Chakrabortya, A., Brantnera, A., Mukainakab, T., Nobukuni, Y., Kuchideb, M., Konoshimac, T., Tokudab, H. and Nishino, H. (2002) Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett., 177, 1-5. (Pubitemid 34102392)
16. Tahiliani, P. and Kar, A. (2000) Achyranthes aspera elevates thyroid hormone level and decreases hepatic lipid peroxidation in male rats. J. Ethnopharmacol., 71, 527-532. (Pubitemid 30642879)
17. Vasudeva Rao, Y., Das, B. K., Jyotyrmayee, P. and Chakrabarti, R. (2006) Effect of Achyranthes aspera on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila. Fish Shellfish Immunol., 20, 263-273. (Pubitemid 41392882)
18. Natelson, S., Scott, M. L. and Beffa, C. (1951) A rapid method for the estimation of urea in biologic fluids, by means of the reaction between diacetyl and urea. Am. J. Clin. Pathol., 21, 275-281.
19. Caraway, W. T. (1963) Uric acid. In Standard method of clinical chemistry (Seligson, D., Ed.), vol.4, Academic Press, New York, pp. 239-247.
20. Slot, C. (1965) Creatinine determinations: A new and specific jaffer's reaction method. Scand. J. Clin. Lab. Invest., 17, 381-387.
21. Rosalki, S. B. and Rau, D. (1972) Serum gamma glutamyl transpeptidase activity in alcoholism. Clin. Chem. Acta, 39, 41-47.
22. Bergmeyer, HU. (eds) (1963) Methods of enzymatic analysis (Bergmeyer, H. U., Ed.), Academic press, New York, p. 1064.
23. Balasubramanian, M. P., Dhandaythapani, S., Nellaiyappan, K. and Ramalingam, K. (1983) Comparative Studies on Phosphomonoestrase in helminthes. Helminthologia, 20, 111-120.
24. King, J. (1965a) The dehydrogenase or oxido reductase-lactate dehydrogenase. In Practical Clinical Enzymology (Van, D., Ed.), Nostrand Co. Ltd., London, pp. 83-93.
25. Sapolsky, A. L., Atlman, R. D. and Howell, D. S. (1973) Cathepsin D activity in normal and osteoarthritic human cartilage. Fed. Proc., 32, 1489-1493.
26. Marhun (1976) Rapid colorimetric assay of β- galactosidase and N-acetyl-β-D-glucuronidase in human urine. Clin. Chim. Acta, 73, 453-461.
27. Khalil-Manesh, F., Gonick, H. C., Cohen, A. H., Alinovi, R., Bergmaschi, E.,Mutti, A. and Rosen, V. J. (1992) Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int., 41, 1192-1203.
28. Morrira, E. G., Rosa, G. J. M., Barros, S. B. M., Vassilieff, V. S. and Vassilieff, I. (2001) Antioxidant defense in rat brain regions after developmental lead exposure. Toxicology, 169, 145-151. (Pubitemid 33082120)
29. Lane, R. E. (1968) Diagnosis of inorganic lead poisoning: a statement. Br. Med. J., 23, 501.
30. Gibson, S. L. M., MacKenzie, J. C. and Goldberg, A. (1968) The diagnosis of industrial lead poisoning. Br. J. Ind. Med., 25, 40-51.
31. Sanchez Fructuoso, A. I., Blanco, J., Cano, M., Ortega, L., Arroyo, M., Fernandez, M. C., Prats, D. and Barrientos, A. (2002) Experimental lead nephropathy: treatment with calcium disodium ethylenediamine tetraacetate. Am. J. Kidney Dis., 40, 59-67. (Pubitemid 34701212)
32. Vasudeva, Y., Rao, B. K., Das, P. and Jyotyrmayee, R. (2005) Chakrabarti Effect of Achyranthes aspera on the immunity and survival of Labeo rohita infected with Ae Fish Shellfish Immunol.
33. Valtin, H. (1983) Renal function: Mechanism Preserving Fluid and Solute Balance in Health, 2nd ed., Little Brown, Boston, Toronto.
34. Lin, J. L., Yu, C. C., Lin-Tan, D. T. and Ho, H. H. (2001) Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout. Kid- ney Int., 60, 266-271.
35. Raab, W. P. (1972) Diagnostic value of urinary enzyme determinations. Clin. Chem., 18, 5-25.
36. Gruener, N. (1992) Early detection of changes in kidney function in workers exposed to solvents and heavy metals. Isr. J. Med. Sci., 28, 605-607.
37. Sivaprasad, R., Nagaraj, M. and Varalakshmi, P. (2003) Combined efficacies of lipoic acid and meso- 2,3-dimercaptosuccinic acid on lead-induced erythrocyte membrane lipid peroxidation and antioxidant status in rats. Hum. Exp. Toxicol., 22, 183-192. (Pubitemid 36582594)
38. Ogura, T., Takaoka, M., Yamauchi, T., Oishi, T., Mimura, Y., Hashimoto, M., Asano, N., Yamamura, M., Otsuka, F., Makino, H., Ota, Z. and Takahashi, K. (1996) Changes in urinary enzyme activity and histochemical findings in experimental tubular injury induced by gold sodium thiomalate. J.Med., 27, 41-55. (Pubitemid 26269407)
39. Maruhn, D., Paar, D. and Bomhard, E. (1983) Diagnostic sensitivity of urinary enzymes in experimental kidney damage in the rat. In Biologie Prospective, Comptes Rendus da 5e Collogue' International de Pont-a-mousson, Masson (Galteau, M. M., Siest, G. and Henry, J., Eds.), Paris, pp. 943-945.
40. Vyskocil, A., Pancl, J., Tusl, M., Ettlerova, E., Semecky, V., Kasparova, L., Lauwerys, R. and Bernard, A. (1989) Dose-related proximal tubular dysfunction in male rats chronically exposed to lead. J. Appl. Toxicol., 9, 395-399. (Pubitemid 20021891)
41. Sugawara, E., Nakamura, K., Miyake, T., Fukumura, A. and Seki, Y. (1991) Lipid Peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br. J. Indust. Med., 48, 239-242.
42. Apostolov, I., Zaprianov, Z. and Gylybova, V. (1976) Lysosomal enzyme activity in the serum of rats with experimental lead poisoning. Biull. Eksp. Biol. Med., 82, 1070-1071.
43. Stroo, W. E., and Hook, J. B. (1977) Enzymes of renal origin in urine as indicators of nephrotoxicity, Toxicol. Appl. Pharmacol., 39, 423-434. (Pubitemid 8095644)
44. Pollack, V. E., Bonting, S. L., Muehrcke, R. C. and Kark, R.M. (1960) Alkaline phosphatase and lactate dehydrogenase activities in renal tubular diseases. J. Clin. Invest., 39, 1386-1395.
45. Curthoys, N. P., Rankin, B. B. and Tsao, B. (1980) Membrane association and orientation of rat renal activities capable of degrading glutathione. Int. J. Biochem., 12, 219-222.
46. Sivaprasad, R., Nagaraj, M. and Varalakshmi, P. (2002) Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney. Arch. Toxicol., 76, 437-441. (Pubitemid 34985260)
47. Teichert-Kuliszewska, K. and Nicholls, D. M. (1985) Rat kidney brush-border enzyme activity following subchronic oral lead exposure. Toxicol. Appl. Pharmacol., 77, 211-218. (Pubitemid 15128366)